Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Opdivo

Nivolumab

Open in the dashboard

Part D claims

2,997

Prescriptions dispensed, refills included

Drug cost

$35,778,054

Paid at the pharmacy, in all

Prescribers

124

With 11 or more claims of it

In 2024, Medicare Part D recorded 2,997 claims for Opdivo (nivolumab) from 124 prescribers, at a total drug cost of $35.8 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 27 states and territories
Part D claims for Opdivo by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 22 637 $7,523,683
NY 17 463 $5,678,864
TX 8 402 $5,124,315
FL 14 296 $3,537,244
TN 7 172 $2,162,034
NJ 8 154 $1,765,379
AR 5 93 $706,105
AL 3 92 $1,255,026
NV 5 68 $529,206
MS 1 66 $944,683
OH 2 65 $500,243
NC 4 57 $716,069
HI 3 54 $658,444
PR 4 53 $552,933
PA 4 47 $609,352
The other 12 states and territories
State Prescribers Claims Drug cost
LA 1 44 $514,561
GA 2 37 $554,993
MD 2 36 $486,965
KY 2 29 $274,302
MA 2 27 $354,927
IA 1 22 $167,314
MI 2 22 $257,151
AZ 1 13 $191,362
AK 1 12 $188,425
IL 1 12 $178,222
VA 1 12 $170,471
VI 1 12 $175,782

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 9 of 9
Part D claims for Opdivo by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 90 2,268 $26,950,409
Medical Oncology 14 283 $3,543,642
Internal Medicine 10 229 $2,700,921
Nurse Practitioner 3 57 $452,448
Hematology 3 55 $712,656
Gastroenterology 1 39 $589,097
General Practice 1 25 $349,383
Physician Assistant 1 23 $206,574
Radiation Oncology 1 18 $272,925

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Nader Javadi Hematology-Oncology CA 127 $1,480,490 $81
Asit Choksi Hematology-Oncology TX 114 $1,257,133 None on record
Ghassan Al-Jazayrly Hematology-Oncology CA 88 $630,988 None on record
Swetha Yadav Hematology-Oncology TX 72 $986,078 None on record
Songchuan Guo Hematology-Oncology NY 70 $734,984 $107

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record